Controlled drug release from implantable matrices based on hydrophobia polymers
โ Scribed by Giacomo Di Colo
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 958 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0142-9612
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Weakly basic drugs and their salts exhibit a drop in aqueous solubility at high pH conditions, which can result in low and incomplete release of these drugs from sustained release formulations. The objective of this study is to modulate matrix microenvironmental pH by incorporation of acidic polymer
## Abstract The ideal biomaterial for the repair of bone defects is expected to have good mechanical properties, be fabricated easily into a desired shape, support cell attachment, allow controlled release of bioactive factors to induce bone formation, and biodegrade into nontoxic products to permi
The availability of osteogenic proteins for orthopedic applications has led to great interest in developing delivery systems for these substances. Standard release rate models are applicable in most biological settings, but orthopedic implants usually bear mechanical loads. To determine whether a re
The purpose of this study was to compare the effect of polymer foam morphology and density prior to compaction on the kinetics of isoniazid (INH) release from the final highdensity extruded matrices. The feasibility of preparing low density foams of several biopolymers, including poly(Llactide) (PLL
A glucose-sensitive multilayer film was fabricated by the layer-by-layer (LbL) assembly method with positively charged 21-arm poly [2-(dimethylamino)ethyl methacrylate] (star PDMAEMA) and negatively charged insulin and glucose oxidase (GOD) in the form of {(Star PDMAEMA/Insulin) 4 รพ (Star PDMAEMA/ G